clinicaltrialsarena12 分钟
Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...